BIVALIRUDIN

作品数：20被引量：56H指数：4
导出分析报告
相关领域：医药卫生更多>>
相关作者：张亚臣相银唐勇更多>>
相关机构：上海交通大学医学院附属新华医院青岛科技大学南京工业大学更多>>
相关期刊：《Chinese Medical Journal》《World Journal of Cardiology》《Cardiovascular Innovations and Applications》《现代化工》更多>>
相关基金：国家自然科学基金中国博士后科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=Chinese Medical Journalx
共 条 记 录，以下是1-2
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Efficacy and safety of bivalirudin without post-procedure infusion in patients with coronary heart disease during elective percutaneous coronary intervention:a real-world study被引量：4
《Chinese Medical Journal》2022年第1期116-118,共3页Ping Wang Xin Zhao Qimin Yuan Xiaoxue Yu Lin Yang Xiaozeng Wang 
To the Editor:Antithrombotic therapy is essential to prevent adverse ischemic events during and after percutaneous coronary intervention(PCI).Anticoagulation during PCI is most commonly achieved with heparin or bivali...
关键词：patients CORONARY INFUSION 
Evaluation on the efficacy and safety of domestic bivalirudin during percutaneous coronary intervention被引量：5
《Chinese Medical Journal》2013年第16期3064-3068,共5页XIANG Ding-cheng GU Xiao-long SONG Yao-ming HUANG Wei-jian TANG Liang-qiu YIN Yao-hui GENG Shao-hua ZHOU Hao FAN Wen-mao HU Rong PAN Chun-mei ZHANG Yi XIAO Fang-yi WAN Huai-bin LIU Zeng-zhang 
Background Bivalirudin was widely used as an anticoagulant during coronary interventional procedure in western countries.However,it was not available in China before this clinical trial was designed.This randomized,si...
关键词：BIVALIRUDIN HEPARIN percutaneous coronary intervention ANTICOAGULANT 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部